Literature DB >> 12118108

Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.

Sang Ling Wu1, Pulin Kothari, Thomas M Wheeler, Tommy Reese, John H Connelly.   

Abstract

Chromophobe renal cell carcinomas and renal oncocytomas share morphologic similarities and may present a diagnostic challenge on routine hematoxylin-eosin staining. Currently recommended additional studies of Hale's colloidal iron staining and electron microscopy are often difficult to interpret and technically challenging and may not be readily available. Previous studies have reported conflicting results with regard to the cytokeratin 7 staining pattern in chromophobe renal cell carcinomas and renal oncocytomas. Cytokeratin 20 expression in chromophobe renal cell carcinomas has not previously been studied. Formalin-fixed paraffin-embedded tissue of 11 chromophobe renal cell carcinomas and 21 renal oncocytomas were retrieved from the archived files (1984-2000) of four teaching hospitals. Of the 11 chromophobe renal cell carcinomas, eight stained positive (73%) for cytokeratin 7, one stained focally positive (9%), and two cases (18%) were completely negative. Cytokeratin 7 staining of the 21 oncocytomas revealed 4 positive (19%), 7 focally positive (33%), and 10 negative cases (48%). Cytokeratin 20 was uniformly negative on all 11 cases of chromophobe renal cell carcinomas and all 21 cases of oncocytomas. Cytokeratin 7 does not appear to show the consistent immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas, as has been previously suggested. Cytokeratin 20 immunostaining in chromophobe renal cell carcinomas and renal oncocytomas is uniformly negative. Despite the technical and interpretive challenges of Hale's colloidal iron, it is still the most useful stain in differentiating chromophobe renal cell carcinomas from renal oncocytomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118108     DOI: 10.1097/01.MP.0000017566.29755.8A

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.

Authors:  Maria Pané Foix; Ana Dunatov; Petr Martinek; Enric Condom Mundó; Saul Suster; Maris Sperga; Jose I Lopez; Monika Ulamec; Stela Bulimbasic; Delia Perez Montiel; Reza Alaghehbandan; Kvetoslava Peckova; Krystina Pivovarcikova; Daum Ondrej; Pavla Rotterova; Faruk Skenderi; Kristyna Prochazkova; Martin Dusek; Milan Hora; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2016-09-15       Impact factor: 4.064

Review 2.  Diagnostic approach to eosinophilic renal neoplasms.

Authors:  Oleksandr N Kryvenko; Merce Jorda; Pedram Argani; Jonathan I Epstein
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

3.  Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.

Authors:  Ozgur Mete; Isin Kilicaslan; Mine G Gulluoglu; Veli Uysal
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

4.  Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma.

Authors:  Chisato Ohe; Naoto Kuroda; Kosho Takasu; Hideto Senzaki; Nobuaki Shikata; Tadanori Yamaguchi; Chika Miyasaka; Yorika Nakano; Noriko Sakaida; Yoshiko Uemura
Journal:  Med Mol Morphol       Date:  2012-06-21       Impact factor: 2.309

5.  High endogenous avidin binding activity: an inexpensive and readily available marker for the differential diagnosis of kidney neoplasms.

Authors:  Kazunori Kanehira; Johnny Hu; Thomas Pier; Linda Sebree; Wei Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

6.  Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors.

Authors:  Cord Langner; Beate J Wegscheider; Manfred Ratschek; Luigi Schips; Richard Zigeuner
Journal:  Virchows Arch       Date:  2004-01-16       Impact factor: 4.064

7.  Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.

Authors:  Sarika Jain; Somak Roy; Milon Amin; Marie Acquafondata; Ming Yin; William Laframboise; Sheldon Bastacky; Liron Pantanowitz; Rajiv Dhir; Anil Parwani
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

8.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Authors:  Maria V Yusenko; Roland P Kuiper; Tamas Boethe; Börje Ljungberg; Ad Geurts van Kessel; Gyula Kovacs
Journal:  BMC Cancer       Date:  2009-05-18       Impact factor: 4.430

9.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18

Review 10.  Biopsy of renal masses: when and why.

Authors:  V Anik Sahni; Stuart G Silverman
Journal:  Cancer Imaging       Date:  2009-07-06       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.